ResMed Inc. Files Conflict Minerals Disclosure Report for 2024

An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.

ResMed Inc. has filed a Specialized Disclosure Report, Form SD, in compliance with the Securities Exchange Act Rule 13p-1 for the reporting period of January 1 to December 31, 2024. The report addresses the company’s conflict minerals disclosure, detailing the reasonable country of origin inquiry process and its outcomes. This disclosure is significant as it reflects ResMed’s commitment to corporate governance and ethical sourcing, potentially impacting its reputation and stakeholder trust.

The most recent analyst rating on (AU:RMD) stock is a Buy with a A$33.70 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.

More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

ResMed Inc. is a company based in San Diego, California, operating in the healthcare industry. It specializes in the development and manufacturing of products and services for sleep disorders, respiratory care, and connected health solutions.

Average Trading Volume: 1,347,878

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$56.23B

For an in-depth examination of RMD stock, go to TipRanks’ Stock Analysis page.